Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Reduced airway levels of fatty-acid binding protein 4 in COPD, relationship with airway infection and disease severity

  • Perea, Lidia|||0000-0002-1624-0012
  • Rodrigo-Troyano, Ana
  • Cantó, Elisabet|||0000-0002-1782-1855
  • Domínguez-Álvarez, Marisol
  • Giner, Jordi|||0000-0002-3044-2059
  • Sánchez Reus, Ferran|||0000-0002-6800-5487
  • Villar, Judit|||0000-0003-2813-8426
  • Quero, Sara|||0000-0002-6454-6358
  • Garcia-Nuñez, Marian|||0000-0002-5158-3758
  • Marín, Alicia|||0000-0002-9358-2120
  • Monso, Eduard|||0000-0003-1876-3092
  • Faner, Rosa|||0000-0002-8159-0115
  • Agustí, Àlvar
  • Vidal, Silvia|||0000-0002-3909-6682
  • Sibila, Oriol|||0000-0002-4833-6713
For still unclear reasons, chronic airway infection often occurs in patients with Chronic Obstructive Pulmonary Disease (COPD), particularly in those with more severe airflow limitation. Fatty-acid binding protein 4 (FABP4) is an adipokine involved in the innate immune response against infection produced by alveolar macrophages (Mɸ). We hypothesized that airway levels of FABP4 may be altered in COPD patients with chronic airway infection. In this prospective and controlled study we: (1) compared airway FABP4 levels (ELISA) in induced sputum, bronchoalveolar lavage fluid (BALF) and plasma samples in 52 clinically stable COPD patients (65.2 ± 7.9 years, FEV 59 ± 16% predicted) and 29 healthy volunteers (55.0 ± 12.3 years, FEV 97 ± 16% predicted); (2) explored their relationship with the presence of bacterial airway infection, defined by the presence of potentially pathogenic bacteria (PPB) at ≥10 3 colony-forming units/ml in BALF; (3) investigated their relationship with the quantity and proportion of Mɸ in BALF (flow cytometry); and, (4) studied their relationship with the severity of airflow limitation (FEV), GOLD grade and level of symptoms (CAT questionnaire). We found that: (1) airway levels of FABP4 (but not plasma ones) were reduced in COPD patients vs. controls [219.2 (96.0-319.6) vs. 273.4 (203.1-426.7) (pg/ml)/protein, p = 0.03 in BALF]; (2) COPD patients with airway infection had lower sputum FABP4 levels [0.73 (0.35-15.3) vs. 15.6 (2.0-29.4) ng/ml, p = 0.02]; (3) in COPD patients, the number and proportion of Mɸ were positively related with FABP4 levels in BALF; (4) BALF and sputum FABP4 levels were positively related with FEV, negatively with the CAT score, and lowest in GOLD grade D patients. Airway FABP4 levels are reduced in COPD patients, especially in those with airway infection and more severe disease. The relationship observed between Mɸ and airway FABP4 levels supports a role for FABP4 in the pathogenesis of airway infection and disease severity in COPD.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Relationship between the respiratory microbiome and the severity of airflow limitation, history of exacerbations and circulating eosinophils in COPD patients

  • Millares, Laura|||0000-0002-0242-0274
  • Pascual-Guardia, Sergi|||0000-0002-6567-0916
  • Montón, Concepción
  • Garcia-Nuñez, Marian|||0000-0002-5158-3758
  • Lalmolda, Cristina|||0000-0002-1128-9028
  • Faner, Rosa|||0000-0002-8159-0115
  • Casadevall, Carme|||0000-0001-6458-8972
  • Setó, Laia
  • Capilla, Silvia|||0000-0002-7274-2973
  • Moreno Gomez de Bonilla, Amalia|||0009-0005-7405-1833
  • Castro Acosta, Ady|||0000-0001-7591-6011
  • Alvarez-Martinez, Carlos José
  • Sibila, Oriol|||0000-0002-4833-6713
  • Peces-Barba, Germán
  • Cosio, Borja G.|||0000-0002-6388-8209
  • Agustí, Àlvar
  • Gea Guiral, Joaquim|||0000-0001-8718-7346
  • Monso, Eduard|||0000-0003-1876-3092
The respiratory microbiome is altered in COPD patients but its relationship with core components of the disease, such as the severity of airflow limitation, the frequency of exacerbations or the circulating levels of eosinophils, is unclear. Cross-sectional study comprising 72 clinically stable COPD patients (mean age 68 [SD 7.9] years; FEV1 48.7 [SD 20.1]% of reference) who provided spontaneous sputum samples for 16S rRNA gene amplification and sequencing. The microbiome composition was analysed with QIIME. We observed that: (1) more severe airflow limitation was associated with reduced relative abundance (RA) of Treponema and an increase in Pseudomonas ; (2) patients with ≥2 exacerbations the previous year showed a significantly different bacterial community with respect to non-exacerbators (p = 0.014), with changes in 13 genera, including an increase of Pseudomonas, and finally, (3) peripheral eosinophils levels ≥2% were associated with more diverse microbiome [Chao1 224.51 (74.88) vs 277.39 (78.92) p = 0.006; Shannon 3.94 (1.05) vs 4.54 (1.06) p = 0.020], and a significant increase in the RAs of 20 genera. The respiratory microbiome in clinically stable COPD patients varies significantly according to the severity of airflow limitation, previous history of exacerbations and circulating eosinophils levels. The online version of this article (10.1186/s12890-019-0867-x) contains supplementary material, which is available to authorized users.